Immune-epithelial cell cross-talk enhances antiviral responsiveness to SARS-CoV-2 in children

EMBO Rep. 2023 Dec 6;24(12):e57912. doi: 10.15252/embr.202357912. Epub 2023 Oct 11.

Abstract

The risk of developing severe COVID-19 rises dramatically with age. Schoolchildren are significantly less likely than older people to die from SARS-CoV-2 infection, but the molecular mechanisms underlying this age-dependence are unknown. In primary infections, innate immunity is critical due to the lack of immune memory. Children, in particular, have a significantly stronger interferon response due to a primed state of their airway epithelium. In single-cell transcriptomes of nasal turbinates, we find increased frequencies of immune cells and stronger cytokine-mediated interactions with epithelial cells, resulting in increased epithelial expression of viral sensors (RIG-I, MDA5) via IRF1. In vitro, adolescent peripheral blood mononuclear cells produce more cytokines, priming A549 cells for stronger interferon responses to SARS-CoV-2. Taken together, our findings suggest that increased numbers of immune cells in the airways of children and enhanced cytokine-based interactions with epithelial cells tune the setpoint of the epithelial antiviral system. Our findings shed light on the molecular basis of children's remarkable resistance to COVID-19 and may suggest a novel concept for immunoprophylactic treatments.

Keywords: RIG-I like receptors; SARS-CoV-2; age-dependence of disease; children; interferon response.

MeSH terms

  • Adolescent
  • Aged
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • COVID-19*
  • Child
  • Cytokines
  • Epithelial Cells
  • Humans
  • Immunity, Innate
  • Interferons
  • Leukocytes, Mononuclear
  • SARS-CoV-2*

Substances

  • Interferons
  • Cytokines
  • Antiviral Agents